OPKO HEALTH, INC. CREDIT AGREEMENTCredit Agreement • March 2nd, 2020 • Opko Health, Inc. • Pharmaceutical preparations • Florida
This Credit Agreement (this "Agreement") is made as of the 25th day of February, 2020 by and among OPKO Health, Inc., a Delaware corporation (the "Company") and Frost Gamma Investments Trust, a Florida trust (the "Lender").
AMENDMENT NO. 11 TO CREDIT AGREEMENTCredit Agreement • March 2nd, 2020 • Opko Health, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 11 TO CREDIT AGREEMENT (this “Amendment”), dated as of February 24, 2020, is entered into among BIO-REFERENCE LABORATORIES, INC., a New Jersey corporation (“Company”), the Subsidiary Borrowers party hereto (“Subsidiary Borrowers,” and together with Company, each a “Borrower” and, collectively, the “Borrowers”), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as the administrative agent for the Lenders (the “Administrative Agent”).
AMENDMENT NO. 10 TO CREDIT AGREEMENTCredit Agreement • March 2nd, 2020 • Opko Health, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 10 TO CREDIT AGREEMENT (this “Amendment”), dated as of November 4, 2019, is entered into among BIO-REFERENCE LABORATORIES, INC., a New Jersey corporation (“Company”), the Subsidiary Borrowers party hereto (“Subsidiary Borrowers,” and together with Company, each a “Borrower” and, collectively, the “Borrowers”), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as the administrative agent for the Lenders (the “Administrative Agent”).
